Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $2.14 per share which beat the analyst consensus estimate of $2.00 by 7 percent. This is a 19.55 percent increase over earnings of $1.79 per share from the same period last year. The company reported quarterly sales of $290.40 million which beat the analyst consensus estimate of $279.92 million by 3.74 percent. This is a 19.24 percent increase over sales of $243.55 million the same period last year.
UBS Upgrades FactSet Research Systems to Neutral, Raises Price Target to $415
UBS analyst Alex Kramm upgrades FactSet Research Systems (NYSE:FDS) from Sell to Neutral and raises the price target from $303 to $415.